ABUS vs POOL
Arbutus Biopharma Corp (ABUS) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the ABUS and POOL stock pages for the full models.
Not investment advice.